According to an article by Norman on off-label use of drugs and medical devices, such processes can expose patients to treatments that have not been formally tested, increasing potential medical risks ...
A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results